Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

N/AActive Not RecruitingNCT06916858

Chulalongkorn University37 enrolled

Overview

cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent type 1 in-laboratory polysomnography and type 3 HSAT within 1 month apart

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

OSA

Interventions

home sleep testDEVICE

Apnealink air

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * difficult-to-treat asthma . * Patients aged 18 years or older Exclusion Criteria: * Patients or volunteers unable to undergo type 1 and type 3 sleep studies, * Patients with symptoms compatible with other sleep disorders, * Patients with a history of or current stroke or transient ischemic attack and Other chronic respiratory diseases. * Patients diagnosed with obstructive sleep apnea

Locations (1)

Tidarat Somreusean

Bangkok, Thailand

Outcomes

Primary Outcomes

prevalence of OSA in patients with difficult-to-treat asthma

Time frame: up to 4 months

Secondary Outcomes

assess the accuracy of type 3 home sleep apnea test (HSAT)

number of participant who have same diagnosed OSA with type 3 HSAT compare to type 1 sleep test * AHI * ODI

Time frame: up to 1 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.